TrialClinical and translational science2025

Safety, Pharmacokinetics and Target Engagement of a Novel Brain Penetrant RIPK1 Inhibitor (SIR9900) in Healthy Adults and Elderly Participants.

Ofer Michael Gonen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.